Literature DB >> 34865121

Cisplatin fastens chromatin irreversibly even at a high chloride concentration.

Hyeon-Min Moon1,2, Jin-Sung Park1, Il-Buem Lee1,2, Young-Im Kang2, Hae Jun Jung2, Dongju An3, Yumi Shin3, Min Ji Kim4, Hugh I Kim4, Ji-Joon Song3, Jaehoon Kim3, Nam-Kyung Lee5, Seok-Cheol Hong1,2.   

Abstract

Cisplatin is one of the most potent anti-cancer drugs developed so far. Recent studies highlighted several intriguing roles of histones in cisplatin's anti-cancer effect. Thus, the effect of nucleosome formation should be considered to give a better account of the anti-cancer effect of cisplatin. Here we investigated this important issue via single-molecule measurements. Surprisingly, the reduced activity of cisplatin under [NaCl] = 180 mM, corresponding to the total concentration of cellular ionic species, is still sufficient to impair the integrity of a nucleosome by retaining its condensed structure firmly, even against severe mechanical and chemical disturbances. Our finding suggests that such cisplatin-induced fastening of chromatin can inhibit nucleosome remodelling required for normal biological functions. The in vitro chromatin transcription assay indeed revealed that the transcription activity was effectively suppressed in the presence of cisplatin. Our direct physical measurements on cisplatin-nucleosome adducts suggest that the formation of such adducts be the key to the anti-cancer effect by cisplatin.
© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34865121      PMCID: PMC8643659          DOI: 10.1093/nar/gkab922

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  65 in total

1.  Overstretching DNA at 65 pN does not require peeling from free ends or nicks.

Authors:  D Hern Paik; Thomas T Perkins
Journal:  J Am Chem Soc       Date:  2011-01-05       Impact factor: 15.419

2.  Cisplatin interaction with cysteine and methionine, a theoretical DFT study.

Authors:  Tomás Zimmermann; Michal Zeizinger; Jaroslav V Burda
Journal:  J Inorg Biochem       Date:  2005-09-23       Impact factor: 4.155

3.  The presence of nucleosomes on a DNA template prevents initiation by RNA polymerase II in vitro.

Authors:  J A Knezetic; D S Luse
Journal:  Cell       Date:  1986-04-11       Impact factor: 41.582

4.  Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity.

Authors:  Elizabeth S McDonald; Kelli R Randon; Andrew Knight; Anthony J Windebank
Journal:  Neurobiol Dis       Date:  2005-03       Impact factor: 5.996

Review 5.  Overcoming the nucleosome barrier during transcript elongation.

Authors:  Steven J Petesch; John T Lis
Journal:  Trends Genet       Date:  2012-03-31       Impact factor: 11.639

6.  Quantitative analysis of single-molecule force spectroscopy on folded chromatin fibers.

Authors:  He Meng; Kurt Andresen; John van Noort
Journal:  Nucleic Acids Res       Date:  2015-03-16       Impact factor: 16.971

7.  Investigation of the elasticity of a cisplatin-DNA adduct via single-molecule measurements and bimodal modeling.

Authors:  Nam-Kyung Lee; Jin-Sung Park; Albert Johner; Sergei Obukhov; Ju-Yong Hyon; Kyoung J Lee; Seok-Cheol Hong
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2009-04-22

Review 8.  Cisplatin: mode of cytotoxic action and molecular basis of resistance.

Authors:  Zahid H Siddik
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

Review 9.  Cisplatin and platinum drugs at the molecular level. (Review).

Authors:  Teni Boulikas; Maria Vougiouka
Journal:  Oncol Rep       Date:  2003 Nov-Dec       Impact factor: 3.906

10.  Transition dynamics and selection of the distinct S-DNA and strand unpeeling modes of double helix overstretching.

Authors:  Hongxia Fu; Hu Chen; Xinghua Zhang; Yuanyuan Qu; John F Marko; Jie Yan
Journal:  Nucleic Acids Res       Date:  2010-12-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.